Status:
COMPLETED
The Effects of e+Shots Energy Beverage on Mental Energy
Lead Sponsor:
Clarkson University
Collaborating Sponsors:
Isagenix International LLC
Conditions:
Caffeine
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
The aim of the research project is to determine the changes in motivation to perform mental and physical tasks, feelings of vigor and fatigue, mental task vigilance and fine motor function after consu...
Detailed Description
Enrolled participants who are low consumers of caffeine will be administered either a placebo (3mg caffeine), caffeinated placebo (\~100mg of caffeine) or e+shot first and then will be crossed over to...
Eligibility Criteria
Inclusion
- Ages 18-45
- Body Mass Index (BMI) \< 30
- Profile of Mood Status Short Scale (POMS) score \<13 on the energy scale
- Energy and Fatigue trait scale score \<=10
- Consumption of \<200mg of caffeine/day
- Consumption of \<150 servings of polyphenols/month
Exclusion
- Subjects taking prescription or over the counter medications (except for oral contraceptives) for a chronic medical condition or recreational drugs will be excluded Chronic medical conditions are any health condition that is expected to last more than 3 months and requires on going medical care such as coronary artery disease, multiple sclerosis, etc..
- Women who are pregnant or may be trying to become pregnant
- Women who are breastfeeding
- People who have been diagnosed with heart conditions and/or hypertension
- People who have liver disorders
- People who have sensitivity or allergy to caffeine
- People who have bipolar disorder
- People who have iron deficiency
- People who are allergic to plants of the Asteraceae/Compositae/Daisy family
- Day of testing
- Subjects who have had a change of ±2 hours of sleep from their regular sleep time will be re-scheduled.
- If subjects begin taking a prescription or over the counter medication for an acute condition (i.e. required to take the prescription or over the counter medication for \< 3 months) during the study they will be given the option of continuing the study after they are no longer taking the prescription or over the counter medication or dropping out of the study.
- If subjects are diagnosed with a chronic condition that requires the use of prescription medications for \> 3 months after they have started the study they will be eliminated from the study.
- Resting systolic BP \> 180mmHg and diastolic BP \> 90mmHg after consuming the caffeine beverage.
Key Trial Info
Start Date :
September 26 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2016
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03850275
Start Date
September 26 2015
End Date
December 15 2016
Last Update
August 2 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.